News
Eli Lilly won’t lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an ...
Novo Nordisk has slashed its full-year revenue and profit forecasts for the first time since launching its blockbuster weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results